CVS
CVS Health Corporation NYSE Listed Nov 20, 1996$98.32
After hrs
$98.71
+0.40%
Mkt Cap $125.4B
52w Low $58.50
89.9% of range
52w High $102.77
50d MA $88.35
200d MA $80.10
P/E (TTM)
71.3x
EV/EBITDA
19.1x
P/B
1.6x
Debt/Equity
1.2x
ROE
2.4%
P/FCF
16.0x
RSI (14)
70.70
ATR (14)
$2.24
Beta
0.51
50d MA
$88.35
200d MA
$80.10
Avg Volume
8.8M
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
One CVS Drive · Woonsocket, RI 02895 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | TNS | 2.18 | 2.57 | +17.9% | 86.86 | +0.2% | +0.6% | +3.7% | +1.8% | +3.2% | +3.1% | — |
| Feb 10, 2026 | TNS | 1.00 | 1.09 | +9.0% | 75.62 | +0.1% | +1.9% | +1.2% | +0.7% | -0.4% | -0.6% | — |
| Oct 29, 2025 | TNS | 1.37 | 1.60 | +16.8% | 80.60 | -5.6% | -4.9% | +1.9% | +0.4% | -0.5% | +0.6% | — |
| Jul 31, 2025 | TNS | 1.46 | 1.81 | +24.0% | 62.10 | +0.4% | +0.6% | -1.6% | +3.2% | +0.2% | +0.1% | — |
| May 1, 2025 | TNS | 1.70 | 2.25 | +32.4% | 69.45 | +0.4% | -2.9% | -0.5% | -1.3% | +0.8% | +1.6% | — |
| Feb 12, 2025 | TNS | 0.91 | 1.19 | +30.2% | 63.22 | +1.0% | +5.0% | -0.8% | -0.4% | +1.3% | -2.0% | — |
| Nov 6, 2024 | TNS | 1.44 | 1.09 | -24.3% | 61.61 | -0.5% | -7.4% | -2.7% | +0.5% | -3.2% | +0.4% | — |
| Aug 7, 2024 | TNS | 1.73 | 1.83 | +5.8% | 56.47 | -0.3% | +2.4% | -1.3% | -2.3% | +0.0% | +0.3% | — |
| May 1, 2024 | TNS | 1.70 | 1.31 | -22.9% | 56.31 | +0.1% | -2.1% | +1.4% | +0.1% | -0.4% | -1.5% | — |
| Feb 7, 2024 | TNS | 2.01 | 2.12 | +5.5% | 76.05 | -0.2% | -1.3% | +1.7% | +1.3% | -0.9% | -0.2% | — |
| Nov 1, 2023 | TNS | 2.13 | 2.21 | +3.8% | 68.73 | -0.4% | +1.3% | +0.9% | +1.2% | -1.2% | -2.1% | — |
| Aug 2, 2023 | TNS | 2.12 | 2.21 | +4.2% | 76.41 | -0.0% | -2.7% | -1.9% | +1.4% | +0.1% | +0.8% | — |
| May 3, 2023 | BMO | 2.07 | 2.20 | +6.3% | 70.08 | -0.7% | -1.8% | +2.7% | -1.4% | +0.4% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $77.62 | $77.15 | -0.6% | -3.4% | +2.4% | +0.7% | -0.9% | +1.0% |
| Mar 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.14 | $70.40 | +0.4% | +2.4% | +0.9% | +1.4% | -0.3% | +6.7% |
| Mar 12 | Bernstein | Upgrade | Market Perform → Outperform | — | $75.72 | $76.81 | +1.4% | +0.5% | +0.1% | -0.4% | -1.4% | -2.4% |
| Jan 28 | Argus | Maintains | Buy → Buy | — | $72.00 | $71.63 | -0.5% | +2.8% | +0.6% | +0.1% | +1.2% | +1.9% |
| Jan 27 | BofA Securities | Maintains | Buy → Buy | — | $83.87 | $75.39 | -10.1% | -14.2% | +2.8% | +0.6% | +0.1% | +1.2% |
| Jan 6 | Bernstein | Maintains | Market Perform → Market Perform | — | $80.42 | $80.35 | -0.1% | +0.3% | -1.1% | +1.0% | -0.4% | +0.1% |
| Dec 17 | JP Morgan | Maintains | Overweight → Overweight | — | $78.29 | $78.50 | +0.3% | -0.5% | -0.1% | -0.1% | +0.8% | -0.4% |
| Dec 12 | Bernstein | Maintains | Market Perform → Market Perform | — | $80.83 | $81.00 | +0.2% | -1.7% | +0.3% | -1.8% | -0.5% | -0.1% |
| Dec 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 10 | UBS | Maintains | Buy → Buy | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 10 | Baird | Maintains | Outperform → Outperform | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 10 | Truist | Maintains | Buy → Buy | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 10 | Barclays | Maintains | Overweight → Overweight | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 10 | Mizuho | Maintains | Outperform → Outperform | — | $78.24 | $78.99 | +1.0% | +0.9% | +2.4% | -1.7% | +0.3% | -1.8% |
| Dec 5 | Bernstein | Maintains | Market Perform → Market Perform | — | $76.75 | $76.73 | -0.0% | -1.5% | +1.2% | +2.2% | +0.9% | +2.4% |
| Nov 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $80.26 | $79.23 | -1.3% | -1.3% | -1.8% | +0.8% | -0.6% | -1.8% |
| Nov 3 | TD Cowen | Maintains | Buy → Buy | — | $78.15 | $78.06 | -0.1% | +0.4% | -0.5% | +0.6% | +0.1% | +0.4% |
| Oct 30 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $80.60 | $76.08 | -5.6% | -4.9% | +1.9% | +0.4% | -0.5% | +0.6% |
| Oct 30 | Evercore ISI | Maintains | Outperform → Outperform | — | $80.60 | $76.08 | -5.6% | -4.9% | +1.9% | +0.4% | -0.5% | +0.6% |
| Oct 30 | Truist | Maintains | Buy → Buy | — | $80.60 | $76.08 | -5.6% | -4.9% | +1.9% | +0.4% | -0.5% | +0.6% |
| Oct 30 | RBC Capital | Maintains | Outperform → Outperform | — | $80.60 | $76.08 | -5.6% | -4.9% | +1.9% | +0.4% | -0.5% | +0.6% |
| Oct 24 | UBS | Maintains | Buy → Buy | — | $81.07 | $81.52 | +0.6% | +1.1% | +0.6% | -0.3% | -1.9% | -4.9% |
| Oct 14 | Morgan Stanley | Maintains | Overweight → Overweight | — | $78.44 | $78.31 | -0.2% | +1.6% | +1.3% | +0.9% | +1.4% | -0.0% |
| Oct 9 | Mizuho | Maintains | Outperform → Outperform | — | $76.93 | $77.25 | +0.4% | -0.2% | +1.5% | +0.7% | +1.6% | +1.3% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $76.84 | $77.50 | +0.9% | +0.4% | -0.2% | -0.2% | +1.5% | +0.7% |
| Sep 22 | Evercore ISI | Maintains | Outperform → Outperform | — | $74.92 | $74.32 | -0.8% | +0.3% | +1.8% | -0.2% | -2.3% | +1.6% |
| Sep 5 | Bernstein | Maintains | Market Perform → Market Perform | — | $73.69 | $73.38 | -0.4% | +0.1% | -4.8% | +2.1% | +3.1% | +0.9% |
| Sep 4 | Barclays | Maintains | Overweight → Overweight | — | $73.32 | $73.42 | +0.1% | +0.5% | +0.1% | -4.8% | +2.1% | +3.1% |
| Aug 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $71.21 | $71.25 | +0.1% | +0.5% | +0.5% | +0.3% | +1.4% | +1.3% |
| Aug 18 | UBS | Upgrade | Neutral → Buy | — | $68.60 | $70.28 | +2.4% | +2.3% | +1.1% | -0.2% | +0.9% | -0.2% |
| Aug 14 | Baird | Upgrade | Neutral → Outperform | — | $65.90 | $66.61 | +1.1% | +1.3% | +2.8% | +2.3% | +1.1% | -0.2% |
| Aug 1 | Barclays | Maintains | Overweight → Overweight | — | $62.10 | $62.32 | +0.4% | +0.6% | -1.6% | +3.2% | +0.2% | +0.1% |
| Aug 1 | Morgan Stanley | Maintains | Overweight → Overweight | — | $62.10 | $62.32 | +0.4% | +0.6% | -1.6% | +3.2% | +0.2% | +0.1% |
| Jul 22 | UBS | Maintains | Neutral → Neutral | — | $61.64 | $61.09 | -0.9% | -0.9% | +1.3% | -5.0% | +3.3% | -1.7% |
| Jun 30 | Jefferies | Maintains | Buy → Buy | — | $68.49 | $68.68 | +0.3% | +0.7% | +0.9% | -4.3% | +1.2% | -1.1% |
| Jun 2 | Barclays | Maintains | Overweight → Overweight | — | $64.04 | $63.51 | -0.8% | -0.7% | -0.0% | -0.0% | -0.8% | +0.8% |
| May 12 | Truist | Maintains | Buy → Buy | — | $66.97 | $65.66 | -2.0% | -3.2% | -6.7% | -0.8% | +0.7% | +3.4% |
| May 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $67.10 | $66.92 | -0.3% | -1.3% | +0.8% | +1.6% | -1.3% | -3.2% |
| May 5 | RBC Capital | Maintains | Outperform → Outperform | — | $67.46 | $68.23 | +1.1% | -0.5% | -1.3% | +0.8% | +1.6% | -1.3% |
| May 2 | Barclays | Maintains | Overweight → Overweight | — | $69.45 | $69.75 | +0.4% | -2.9% | -0.5% | -1.3% | +0.8% | +1.6% |
| May 2 | UBS | Maintains | Neutral → Neutral | — | $69.45 | $69.75 | +0.4% | -2.9% | -0.5% | -1.3% | +0.8% | +1.6% |
| Apr 15 | Baird | Maintains | Neutral → Neutral | — | $69.20 | $69.54 | +0.5% | -0.4% | -0.5% | -1.8% | -3.2% | +0.4% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $68.97 | $69.00 | +0.0% | +0.8% | -0.4% | -0.4% | -0.5% | -1.8% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $67.63 | $66.44 | -1.8% | +3.8% | -1.7% | +0.8% | -0.4% | -0.4% |
| Mar 21 | Piper Sandler | Maintains | Overweight → Overweight | — | $68.64 | $68.46 | -0.3% | -2.3% | +0.8% | -1.6% | +1.1% | +0.6% |
| Feb 18 | JP Morgan | Maintains | Overweight → Overweight | — | $65.83 | $64.85 | -1.5% | -0.4% | +1.3% | -2.0% | -2.5% | -0.7% |
| Feb 13 | Truist | Maintains | Buy → Buy | — | $63.22 | $63.86 | +1.0% | +5.0% | -0.8% | -0.4% | +1.3% | -2.0% |
| Feb 13 | Leerink Partners | Upgrade | Market Perform → Outperform | — | $63.22 | $63.86 | +1.0% | +5.0% | -0.8% | -0.4% | +1.3% | -2.0% |
| Feb 13 | Barclays | Maintains | Overweight → Overweight | — | $63.22 | $63.86 | +1.0% | +5.0% | -0.8% | -0.4% | +1.3% | -2.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | Mandadi TilakOff | EVP, Chief Exp & Tech Officer | Sell | 69,551 | $89.58 | $6.2M | 10,133 | +3.18% | +0.10% |
8-K · 5.02
!!! Very High
CVS Health Corporation -- 8-K 5.02: Executive Change
May 18
8-K · 2.02
!! High
CVS Health Corporation -- 8-K 2.02: Earnings Results
CVS Health announced Q1 2026 earnings results on May 6, 2026, providing investors with updated financial performance metrics and operational insights for the quarter ending March 31, 2026.
May 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CVS appointed Gallina, an independent director and audit committee financial expert, strengthening board oversight and governance credibility, which typically reassures investors about financial integrity and risk management.
Mar 19
8-K
CVS HEALTH CORPORATION -- 8-K Filing
CVS Health's Aetna subsidiary has improved prior authorization processing to approve over 95% of eligible requests within 24 hours, potentially reducing friction in healthcare delivery and strengthening competitive positioning in insurance services.
Feb 10
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 82,650,076 | $5.9B | New | Mar 2026 |
| 2 | Capital World Investors | 77,248,642 | $5.5B | Added | Mar 2026 |
| 3 | Dodge & Cox | 51,780,116 | $3.7B | Reduced | Mar 2026 |
| 4 | Morgan Stanley | 40,747,548 | $3.2B | Added | Dec 2025 |
| 5 | Fmr Llc | 31,196,890 | $2.2B | Reduced | Mar 2026 |
| 6 | Jpmorgan Chase & Co | 29,527,125 | $2.1B | Reduced | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 25,997,348 | $1.9B | New | Mar 2026 |
| 8 | Invesco Ltd. | 25,138,946 | $1.8B | Added | Mar 2026 |
| 9 | Capital Research Global Investors | 20,012,332 | $1.4B | Added | Mar 2026 |
| 10 | Davis Selected Advisers | 12,760,511 | $1.0B | Added | Dec 2025 |
| 11 | Pzena Investment Management Llc | 13,773,053 | $989M | Reduced | Mar 2026 |
| 12 | Northern Trust Corp | 11,641,549 | $836M | Reduced | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 9,351,969 | $672M | Reduced | Mar 2026 |
| 14 | Bank Of New York Mellon Corp | 9,030,161 | $649M | Reduced | Mar 2026 |
| 15 | Royal Bank Of Canada | 8,984,614 | $645M | Reduced | Mar 2026 |
| 16 | Clearbridge Investments, Llc | 8,774,708 | $630M | — | Mar 2026 |
| 17 | Glenview Capital Management | 8,196,799 | $589M | New | Mar 2026 |
| 18 | Wells Fargo & Company/mn | 8,111,035 | $583M | New | Mar 2026 |
| 19 | Amundi | 7,370,938 | $529M | New | Mar 2026 |
| 20 | Franklin Resources Inc | 6,241,607 | $448M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$125.45B
Enterprise Value
$188.26B
P/E (TTM)
71.34x
Forward P/E
13.73x
PEG Ratio
-0.92x
P/B
1.65x
P/S
0.31x
P/FCF
16.01x
EV/EBITDA
19.09x
Shares Out
1.27B
Financials (TTM)
Revenue
$402.07B
Net Income
$1.77B
EBITDA
$9.86B
Free Cash Flow
$7.81B
Op Cash Flow
$10.64B
EPS Basic
$1.40
EPS Diluted
$1.39
EPS Forward
$7.16
Gross Margin
13.8%
Op Margin
2.6%
Net Margin
0.4%
Balance Sheet
Total Assets
$261.06B
Total Liab.
$185.68B
Total Equity
$75.38B
Cash
$10.66B
LT Debt
$72.88B
Book Value/Sh
$59.50
Debt/Equity
1.24x
Current Ratio
0.84
Quick Ratio
0.63
Returns & Growth
ROE
2.4%
ROA
0.7%
ROIC
4.7%
Rev Growth YoY
+7.8%
EPS Growth YoY
-61.8%
Price Returns
2W
-6.4%
1M
+9.2%
3M
+13.9%
6M
+13.2%
12M
+42.1%
Technicals
52W High
$102.77
52W Low
$58.50
50d MA
$88.35
200d MA
$80.10
RSI (14)
70.70
ATR (14)
$2.24
Beta
0.51
Avg Volume
8.8M
Dividends
Div Rate
$2.68
Div Yield
3.3%
Frequency
4
Ex-Div Date
Apr 23, 2026
Analyst Price Targets
Consensus
$95.20
High
$101.00
Low
$90.00
Median
$94.50
Data updated apr 25, 2026 4:11am
· Source: financialmodelingprep.com